Evidence map›Paper›PMID 41440256›Full record

ReviewBiosensors2025

Recent Advances in the Detection of Aflatoxin M1 in Milk and Dairy Products.

Anna Maria Maurelli, Lucia Catucci, Michelangelo Pascale, Sabato D'Auria, Maria Staiano

Abstract readReview
In one paragraph

Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna Maria MaurelliURT-Bari, Institute of Food Sciences, National Research Council of Italy, Via Orabona 4, 70126 Bari, Italy.ORCID 0000-0001-9124-0007
Lucia CatucciDepartment of Chemistry, University of Bari, Via Orabona 4, 70126 Bari, Italy.ORCID 0000-0003-2206-9247
Michelangelo PascaleInstitute of Food Sciences, National Research Council of Italy, Via Roma 64, 83100 Avellino, Italy.ORCID 0000-0002-3898-1030
Sabato D'AuriaInstitute of Food Sciences, National Research Council of Italy, Via Roma 64, 83100 Avellino, Italy.ORCID 0000-0002-3082-8947
Maria StaianoInstitute of Food Sciences, National Research Council of Italy, Via Roma 64, 83100 Avellino, Italy.ORCID 0000-0003-0223-1825

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is an increasing demand to design user-friendly specific assays for the detection of analytes of interest for healthcare, environment, and agrifood. Modern biotechnology has approached this problem by using proteins, enzymes, or RNA/DNA fragments (aptamers) as biological recognition elements for biosensors/assays. The idea is to exploit the extremely wide range of selective affinities sculpted into the various proteins or aptamers by biological evolution. The number of compounds specifically recognized by different proteins and aptamers is very large and ranges from small molecules to macromolecules. The advantages of using proteins and aptamers as molecular recognition elements (MRE) for assays/biosensors are many, and involve relatively low costs in design and synthesis, water solubility, and finally high specificity. Many of the analytes of interest in the food control industry are relatively small. In this case, aptamers and antibodies are widely used as specific MREs in designing advanced biosensors. Aflatoxin B1 (AFB1) is the most frequently found aflatoxin in contaminated food samples, and is one of the most potent natural compounds in terms of genotoxicity and carcinogenicity. Aflatoxin M1 (AFM1) is the hydroxylated metabolite of AFB1 and is usually found in milk and milk products as a carry-over of AFB1 in animals that have ingested contaminated feed. AFM1 is also found in human milk, and has been shown to be hepatotoxic and carcinogenic. Here, we present recent advances in assays and biosensors based on the use of antibodies and aptamers as MREs that have been developed for monitoring the presence of AFM1 in milk and dairy products. The limitations and advantages of aptamer- and antibody-based assays/biosensors are discussed, as well as future research perspectives.

Indexed as

Aflatoxin M1Biosensing TechniquesDairy ProductsMilkAnimalsAptamers, NucleotideFood ContaminationHumansAflatoxin M1Aptamers, NucleotideAflatoxin M1aptamer-based assayaptasensorsbiosensorsdairy productsimmunoassaysmilk

Identifiers

PMID41440256
PMCPMC12730753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.